Cowen and Company’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-50,300
Closed -$3.77K 709
2023
Q1
$3.77K Buy
+50,300
New +$2.75K ﹤0.01% 486

Cowen and Company's LVACW Position: Q2 2023 in Review

Cowen and Company sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 50,300 shares — an estimated $3.77K sold.

Cowen and Company first reported a position in LVACW in Q1 2023 and held it in 1 quarter. The position peaked at $3.77K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

  • Cowen and Company reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
  • Cowen and Company sold 50,300 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $3.77K.
  • Cowen and Company first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2023 and held it in 1 quarter.
  • Cowen and Company's LAVA Medtech Acquisition Corp. Warrants position peaked at $3.77K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.